تحسس (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "تحسس" in Arabic language version.

refsWebsite
Global rank Arabic rank
4th place
6th place
2nd place
5th place
low place
8,251st place

doi.org

  • Volkow ND، Koob GF، McLellan AT (يناير 2016). "Neurobiologic Advances from the Brain Disease Model of Addiction". N. Engl. J. Med. ج. 374 ع. 4: 363–371. DOI:10.1056/NEJMra1511480. PMID:26816013. Substance-use disorder: A diagnostic term in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) referring to recurrent use of alcohol or other drugs that causes clinically and functionally significant impairment, such as health problems, disability, and failure to meet major responsibilities at work, school, or home. Depending on the level of severity, this disorder is classified as mild, moderate, or severe.
    Addiction: A term used to indicate the most severe, chronic stage of substance-use disorder, in which there is a substantial loss of self-control, as indicated by compulsive drug taking despite the desire to stop taking the drug. In the DSM-5, the term addiction is synonymous with the classification of severe substance-use disorder.
  • Bell IR, Hardin EE, Baldwin CM, Schwartz GE (1995). "زيادة أعراض الجهاز الحوفي وقابليته للتحسس لدى الشباب البالغين الذين لديهم حساسيات من المواد الكيميائية والضوضاء." Environ Res 70(2): 84–97, ببمد8674484, دُوِي:10.1006/enrs.1995.1052.
  • Collingridge GL, Isaac JT, Wang YT (2004). "المعالجة بعد الانتقالية للمستقبل والمرونة المشبكية". Nat Rev Neurosci 5(12): 952–962, ببمد15550950, دُوِي:10.1038/nrn1556.
  • Morimoto K, Fahnestock M, Racine RJ (2004). "نماذج الاضطرام والنوبات الصرعية المستمرة في مرض الصرع: إعادة استثارة المخ". Prog Neurobiol 73(1): 1–60, ببمد15193778, دُوِي:10.1016/j.pneurobio.2004.03.009.
  • Rosen JB, Schulkin J (1998). "من الخوف الطبيعي إلى القلق المرضي". Psychol Rev 105(2): 325–350, دُوِي:10.1037/0033-295X.105.2.325 ببمد9577241.

mssm.edu

neuroscience.mssm.edu

  • "Glossary of Terms". Mount Sinai School of Medicine. Department of Neuroscience. اطلع عليه بتاريخ 2015-02-09.

nih.gov

ncbi.nlm.nih.gov

  • Nestler EJ (ديسمبر 2013). "Cellular basis of memory for addiction". Dialogues Clin. Neurosci. ج. 15 ع. 4: 431–443. PMC:3898681. PMID:24459410. Despite the importance of numerous psychosocial factors, at its core, drug addiction involves a biological process: the ability of repeated exposure to a drug of abuse to induce changes in a vulnerable brain that drive the compulsive seeking and taking of drugs, and loss of control over drug use, that define a state of addiction. ... A large body of literature has demonstrated that such ΔFosB induction in D1-type [nucleus accumbens] neurons increases an animal's sensitivity to drug as well as natural rewards and promotes drug self-administration, presumably through a process of positive reinforcement ... Another ΔFosB target is cFos: as ΔFosB accumulates with repeated drug exposure it represses c-Fos and contributes to the molecular switch whereby ΔFosB is selectively induced in the chronic drug-treated state.41. ... Moreover, there is increasing evidence that, despite a range of genetic risks for addiction across the population, exposure to sufficiently high doses of a drug for long periods of time can transform someone who has relatively lower genetic loading into an addict.
  • Bell IR, Hardin EE, Baldwin CM, Schwartz GE (1995). "زيادة أعراض الجهاز الحوفي وقابليته للتحسس لدى الشباب البالغين الذين لديهم حساسيات من المواد الكيميائية والضوضاء." Environ Res 70(2): 84–97, ببمد8674484, دُوِي:10.1006/enrs.1995.1052.
  • Collingridge GL, Isaac JT, Wang YT (2004). "المعالجة بعد الانتقالية للمستقبل والمرونة المشبكية". Nat Rev Neurosci 5(12): 952–962, ببمد15550950, دُوِي:10.1038/nrn1556.
  • Morimoto K, Fahnestock M, Racine RJ (2004). "نماذج الاضطرام والنوبات الصرعية المستمرة في مرض الصرع: إعادة استثارة المخ". Prog Neurobiol 73(1): 1–60, ببمد15193778, دُوِي:10.1016/j.pneurobio.2004.03.009.
  • Teicher MH, Glod CA, Surrey J, Swett C, Jr (1993). "الإيذاء في فترة الطفولة المبكرة وتصنيفات الجهاز الحوفي لدى مرضى العيادات الخارجية النفسية البالغين". J Neuropsychiatry Clin Neurosci 5(3): 301–306, ببمد8369640.
  • Ji RR, Kohno T, Moore KA, Woolf CJ (2003). "التحسس المركزي والتقوية طويلة المدى: هل يشترك الألم والذاكرة في آليات متشابهة؟" Trends Neurosci 26(12): 696–705, ببمد14624855.
  • Robinson TE, Berridge KC (1993). "الأساس العصبي للرغبة في تعاطي المخدرات: نظرية التحسس التحفيزي للإدمان". Brain Res Brain Res Rev 18(3): 247–291, ببمد8401595.
  • Rosen JB, Schulkin J (1998). "من الخوف الطبيعي إلى القلق المرضي". Psychol Rev 105(2): 325–350, دُوِي:10.1037/0033-295X.105.2.325 ببمد9577241.
  • Post RM (1992). "انتقال جينات الضغط النفسي إلى البيولوجيا العصبية للاضطراب العاطفي المتكرر". Am J Psychiatry 149(8): 999–1010, ببمد1353322.

pubmed.ncbi.nlm.nih.gov

  • Nestler EJ (ديسمبر 2013). "Cellular basis of memory for addiction". Dialogues Clin. Neurosci. ج. 15 ع. 4: 431–443. PMC:3898681. PMID:24459410. Despite the importance of numerous psychosocial factors, at its core, drug addiction involves a biological process: the ability of repeated exposure to a drug of abuse to induce changes in a vulnerable brain that drive the compulsive seeking and taking of drugs, and loss of control over drug use, that define a state of addiction. ... A large body of literature has demonstrated that such ΔFosB induction in D1-type [nucleus accumbens] neurons increases an animal's sensitivity to drug as well as natural rewards and promotes drug self-administration, presumably through a process of positive reinforcement ... Another ΔFosB target is cFos: as ΔFosB accumulates with repeated drug exposure it represses c-Fos and contributes to the molecular switch whereby ΔFosB is selectively induced in the chronic drug-treated state.41. ... Moreover, there is increasing evidence that, despite a range of genetic risks for addiction across the population, exposure to sufficiently high doses of a drug for long periods of time can transform someone who has relatively lower genetic loading into an addict.
  • Volkow ND، Koob GF، McLellan AT (يناير 2016). "Neurobiologic Advances from the Brain Disease Model of Addiction". N. Engl. J. Med. ج. 374 ع. 4: 363–371. DOI:10.1056/NEJMra1511480. PMID:26816013. Substance-use disorder: A diagnostic term in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) referring to recurrent use of alcohol or other drugs that causes clinically and functionally significant impairment, such as health problems, disability, and failure to meet major responsibilities at work, school, or home. Depending on the level of severity, this disorder is classified as mild, moderate, or severe.
    Addiction: A term used to indicate the most severe, chronic stage of substance-use disorder, in which there is a substantial loss of self-control, as indicated by compulsive drug taking despite the desire to stop taking the drug. In the DSM-5, the term addiction is synonymous with the classification of severe substance-use disorder.